Michael H Tardugno bought $26k of IMNN
Executive Chairman of Board at Imunon, Inc.. 25,000 shares at an average of $1.03, traded Aug 15, 2024, filed Aug 16, 2024.
Score components
- +20RoleChair
- +5Trade size$26k at market
- +3Relative to holdingsHoldings up 8%
- +8Price context70% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -8.8%, 3m -36.8%, 6m -21.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-24-027058, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 15, 2024 | POpen-market purchase Imunon Common Stock | +25,000 | $1.03 | $26k | 353,346 | Aug 16, 2024 |
Related signals
Other insiders at Imunon, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | IMNNsell Imunon, Inc. | Susan Eylward General Counsel and Corp Sec | $3,950 2,525 shares | -47% | |
| 25Weak | IMNNsell Imunon, Inc. | Susan Eylward General Counsel and Corp Sec | $3,993 2,449 shares | -46% | |
| 25Weak | IMNNsell Imunon, Inc. | Susan Eylward General Counsel and Corp Sec | $3,977 2,541 shares | -47% | |
| 25Weak | IMNNsell Imunon, Inc. | Susan Eylward General Counsel and Corp Sec | $3,830 2,150 shares | -43% | |
| 20Weak | IMNNsell Imunon, Inc. | Susan Eylward General Counsel and Corp Sec | $1,730 920 shares | -24% | |
| 35Weak | IMNNsell Imunon, Inc. | Susan Eylward General Counsel and Corp Sec | $21k 11,800 shares | -80% | |
| 53Moderate | Imunon, Inc. | Donald P Braun director | $29k 25,000 shares | +4188% | |
| 51Moderate | Imunon, Inc. | Stacy Lindborg President and CEO | $25k 25,000 shares | +10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.